Development of a novel molecular model and the rationalisation of a series of novel inhibitors of 17a-hydroxylase/17,20-Iyase

被引：0

作者：

Acharya, P. ^{[1
]}

Shahid, I. ^{[1
]}

Owen, C. P. ^{[1
]}

Ahmed, S. ^{[1
]}

机构：

[1] Univ W Scotland, Sch Sci, Paisley, Renfrew, Scotland

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 2010年 / 62卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1368 / 1368

页数：1

共 50 条

[21] Synthesis, Biochemical Evaluation and Rationalisation of the Inhibitory Activity of a Range of Derivatives of 2-imidazol-1-yl-1-phenyl-ethanone as Potential Novel Inhibitors of 17α-hydroxylase/17,20-lyase (P-45017α)
Shah, Kruti
Jandu, Baljeet
Abdullah, Ammara
Ahmed, Sabbir
LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (06) : 516 - 522
[22] Novel mutation in cytochrome P450c17 causes complete combined 17α-hydroxylase/17,20-lyase deficiency
Bhangoo, Amrit
Aisenberg, Javier
Chartoff, Amy
Ten, Svetlana
Wallerstein, Robert J.
Wolf, Robin
Auchus, Richard J.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2008, 21 (02): : 185 - 190
[23] A novel point mutation in P450c17 (CYP17) causing combined 17α-hydroxylase/17,20-lyase deficiency
Brooke, A. M.
Taylor, N. F.
Shepherd, J. H.
Gore, M. E.
Ahmad, T.
Lin, L.
Rumsby, G.
Papari-Zareei, M.
Auchus, R. J.
Achermann, J. C.
Monson, J. P.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06): : 2428 - 2431
[24] Two Novel Heterozygous Mutations in the CYP17A1 Gene in a Chinese Patient with 17α-Hydroxylase 17,20-Lyase Deficiency
Sun, Xianglan
Li, Minglong
Wang, Yao
Bi, Ye
DISCOVERY MEDICINE, 2018, 26 (145) : 243 - 249
[25] Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-substituted phenyl alkyl triazole-based compounds as potential inhibitors of 17α-hydroxylase/17,20-lyase (P45017α)
Owen, Caroline P.
Dhanani, Sachin
Patel, Chirag H.
Ahmed, Sabbir
LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (07) : 479 - 483
[26] A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency
Nuzzo, V.
Tauchmanova, L.
Brunetti-Pierri, R.
Zuccoli, A.
Lupoli, G.
Colao, A.
Brunetti-Pierri, N.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (04) : 322 - 324
[27] A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency
V. Nuzzo
L. Tauchmanova
R. Brunetti-Pierri
A. Zuccoli
G. Lupoli
A. Colao
N. Brunetti-Pierri
Journal of Endocrinological Investigation, 2009, 32 : 322 - 324
[28] 17,20-Lyase inhibitors. Part 4: Design, synthesis and structure-activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors
Kaku, Tomohiro
Matsunaga, Nobuyuki
Ojida, Akio
Tanaka, Toshimasa
Hara, Takahito
Yamaoka, Masuo
Kusaka, Masami
Tasaka, Akihiro
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (05) : 1751 - 1770
[29] Two rare forms of congenital adrenal hyperplasia, 11β hydroxylase deficiency and 17-hydroxylase/17,20-lyase deficiency, presenting with novel mutations
Krupali Bulsari
Louise Maple-Brown
Henrik Falhammar
Hormones, 2018, 17 : 127 - 132
[30] 17,20-Lyase inhibitors. Part 3: Design, synthesis, and structure-activity relationships of biphenylylmethylimidazole derivatives as novel 17,20-lyase inhibitors
Kaku, Tomohiro
Tsujimoto, Saori
Matsunaga, Nobuyuki
Tanaka, Toshimasa
Hara, Takahito
Yamaoka, Masuo
Kusaka, Masami
Tasaka, Akihiro
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (07) : 2428 - 2442

← 1 2 3 4 5 →